NutriBand (NTRB) Gross Margin (2018 - 2026)

NutriBand's (NTRB) quarterly Gross Margin came in at 22.2% in Q1 2026, down 2232.0% year-on-year from 1.04% in Q1 2025, and up 12.12% quarter-over-quarter from 19.8% in Q4 2025.

NutriBand (NTRB) Gross Margin (2018 - 2026) Analysis & Trends

NutriBand has disclosed Gross Margin across 9 years of filings, most recently posting 22.2% for Q1 2026.

  • Gross Margin for Q1 2026 came in at 22.2%, down 2232.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 27.81% (down 694.0% YoY), and the FY2026 annual result was 27.81%, down 694.0% from the prior year.
  • Gross Margin came in at 22.2% for Q1 2026 at NutriBand, up from 19.8% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 46.61% in Q2 2023 to a low of 19.8% in Q4 2025.
  • The 5-year median for Gross Margin is 37.14% (2023), against an average of 34.61%.
  • Across the five-year window, Gross Margin soared 3361 bps in 2022 and sank 2275 bps in 2024, its largest moves.
  • NutriBand's Gross Margin stood at 43.48% in 2022, then slipped by 15 bps to 37.14% in 2023, then dropped by 20 bps to 29.58% in 2024, then slumped by 33 bps to 19.8% in 2025, then grew by 12 bps to 22.2% in 2026.
  • The last three Gross Margin figures came in at 22.2% (Q1 2026), 19.8% (Q4 2025), and 25.2% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 86.85%
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 22.20%

Historic Data

Download Data
DateValue
Jan 31, 2026 22.20%
Oct 31, 2025 19.80%
Jul 31, 2025 25.20%
Apr 30, 2025 37.75%
Jan 31, 2025 44.51%
Oct 31, 2024 29.58%
Jul 31, 2024 22.93%
Apr 30, 2024 40.34%
Jan 31, 2024 34.55%
Oct 31, 2023 37.14%
Jul 31, 2023 45.69%
Apr 30, 2023 46.61%
Jan 31, 2023 24.53%
Oct 31, 2022 43.48%
Jul 31, 2022 33.28%
Apr 30, 2022 41.95%
Jan 31, 2022 38.90%
Oct 31, 2021 26.62%
Jul 31, 2021 -0.33%
Apr 30, 2021 54.88%